CYCN
NASDAQ · Biotechnology
Cyclerion Therapeutics Inc
$3.91
-0.01 (-0.26%)
Open$3.92
Previous Close$3.92
Day High$4.45
Day Low$3.81
52W High$8.48
52W Low$1.03
Volume—
Avg Volume19.4K
Market Cap17.37M
P/E Ratio—
EPS$-1.37
SectorBiotechnology
Analyst Ratings
Strong Buy
7 analysts
Price Target
+456.8% upside
Current
$3.91
$3.91
Target
$21.77
$21.77
$14.42
$21.77 avg
$30.48
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 3.08M | 2.84M | 1.11M |
| Net Income | -5,234,413 | -4,347,519 | -131,808 |
| Profit Margin | -170.1% | -161.6% | -11.8% |
| EBITDA | -5,424,137 | -4,755,380 | -161,572 |
| Free Cash Flow | — | — | -153,109 |
| Rev Growth | +8.4% | +8.4% | +14.6% |
| Debt/Equity | — | — | 0.60 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $250.82 | +0.83% | 118.6 | 430.95B |
| AMGN | Amgen Inc | $417.84 | +0.40% | 25.1 | 219.39B |
| GILD | Gilead Sciences Inc | $138.14 | +1.67% | — | 165.85B |
| VRTX | Vertex Pharmaceuticals Inc | $516.44 | -1.77% | 28.3 | 124.51B |
| REGN | Regeneron Pharmaceuticals | $805.97 | +1.00% | 18.4 | 79.53B |
| ALNY | Alnylam Pharmaceuticals Inc | $227.12 | +1.42% | 35.2 | 28.41B |